Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

November 4, 2014

Genzyme Announces Enrollment of First Patient in Phase II Vatelizumab Trial in Relapsing Remitting Multiple Sclerosis

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
Cambridge, Mass. – Nov. 4, 2014 – Genzyme, a Sanofi company, announced today enrollment of the first patient in a…
MS Research Study and Reports

November 4, 2014

Information on the 2014 MS (5 speaker) Symposium in Miami

  • MS Educational Programs
    /
  • MS Genetic Research
    /
  • MS Views and News
    /
  • Multiple Sclerosis
    /
  • Multiple Sclerosis Videos
    /
Program Date: October 25, 2014 This year’s MS Views and News annual symposium was their 5th since being founded in…
MS Educational Programs

November 4, 2014

Postural Sway Is Associated with Disability Status and Cerebellar Dysfunction in People with Multiple Sclerosis: A Preliminary Study

  • MS Research Study and Reports
    /
Background: The aims of this study were to a) examine postural sway in eyes open (EO) and eyes closed (EC)…
MS Research Study and Reports

November 4, 2014

Evaluating the Theoretical Content of Online Physical Activity Information for People with Multiple Sclerosis

  • Alternative therapies and devices for Multiple Sclerosis (MS)
    /
Background: Physical activity can aid people with multiple sclerosis (MS) in managing symptoms and maintaining functional abilities. The Internet is…
Alternative therapies and devices for Multiple Sclerosis (MS)

November 4, 2014

Biogen and the National MS Society weigh in on the first reported death of an MS patient taking Tecfidera who developed PML.

  • Oral MS Medications
    /
October 30, 2014 Biogen Idec Inc., maker of the popular multiple sclerosis (MS) pill dimethyl fumarate (Tecfidera), announced the death…
Oral MS Medications

November 3, 2014

Wales First U.K. Country To Approve Cannabis-Based Medicine for MS Patients

  • Alternative therapies and devices for Multiple Sclerosis (MS)
    /
Welsh health minister Mark Drakeford has announced that Wales has become the first UK country to authorize a cannabis-based medicine…
Alternative therapies and devices for Multiple Sclerosis (MS)

November 3, 2014

Neuroprotective Qualities of Masitinib Drug in Stroke Encouraging For MS Indication

  • MS Research Study and Reports
    /
An encouraging experimental drug that is being developed for Multiple Sclerosis continues to show promise in being able to offer neuroprotective benefits — an…
MS Research Study and Reports

November 1, 2014

Young adults most vulnerable to Multiple Sclerosis

  • MS Research Study and Reports
    /
CHANDIGARH: Young adults especially in the age group of 20-30 are the most vulnerable to Multiple Sclerosis (MS) but an…
MS Research Study and Reports

November 1, 2014

Multiple Sclerosis, Autoimmune Disease Diagnoses, Treatments To Improve Using New DNA Software

  • MS Genetic Research
    /
  • Multiple Sclerosis
    /
Researchers from UC San Francisco, the Broad Institute of MIT and Harvard, and Yale School of Medicine recently developed a software…
MS Genetic Research

November 1, 2014

New iPad App Tracks MS Patient Course

  • Alternative therapies and devices for Multiple Sclerosis (MS)
    /
Researchers at the University of California, San Francisco, have developed a new tool that allows clinicians to track an individual’s…
Alternative therapies and devices for Multiple Sclerosis (MS)

Categories

Latest Blog Posts